4 Stories

FDA Advisers Support Full Approval of Paxlovid

Experts have cautions about drug interactions, rebound COVID-19 cases

(Newser) - Paxlovid is nearing full FDA approval for use against COVID-19 after the drug was endorsed by the agency's panel of advisers on Thursday. The drug has been employed under a Food and Drug Administration emergency use authorization for patients over 50 whose COVID case is considered at high risk...

Walgreens Cuts Deal to Deliver Paxlovid to Homes

Uber, DoorDash partner with chain, greatly expanding access for COVID-19 patients

(Newser) - Walgreens announced Thursday that it has partnered with DoorDash and Uber to have Paxlovid, the oral antiviral therapy for COVID-19, delivered to homes. The company said that the new service will make the drug available to 92% of Americans, ABC News reports, and that its goal is to reach "...

Second Straight Positive Test Will Keep Biden in Isolation

Doctor refers to infection as a rebound case

(Newser) - Update: For the second day in a row, President Biden has tested positive for COVID-19, his doctor said Sunday. Dr. Kevin O'Connor said in a letter that the president's "rebound positivity" wasn't surprising, CBS News reports. It occurs, though not often, among patients who've been...

2nd COVID Pill Is Headed Our Way, but With Caveats

Experts think Merck's molnupiravir will take second stage to Pfizer's Paxlovid due to safety risks

(Newser) - US health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration's authorization of Merck's molnupiravir comes one day after the agency cleared a competing drug from Pfizer . That pill, Paxlovid, is...

4 Stories
Popular on Newser
We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.